Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications

被引:4
作者
Alatawi, Hind M. [1 ]
Alhwiti, Shemah S. [1 ]
Alsharif, Khwlah A. [1 ]
Albalawi, Shyma S. [1 ]
Abusaleh, Shroug M. [1 ]
Sror, Ghada K. [1 ]
Qushawy, Mona [2 ,3 ]
机构
[1] Univ Tabuk, Fac Pharm, Pharm D Program, Tabuk, Saudi Arabia
[2] Univ Tabuk, Fac Pharm, Dept Pharmaceut, Tabuk 71491, Saudi Arabia
[3] Sinai Univ, Fac Pharm, Dept Pharmaceut, Alarish 45511, North Sinai, Egypt
关键词
Nanostructured lipid carriers (NLCs); bioavailability; drug targeting; homogenization; chemotherapy; gene delivery; drug delivery systems; NANOPARTICLES SLN; ORAL BIOAVAILABILITY; DESIGN; FORMULATION; CLOTRIMAZOLE; COMBINATION; STABILITY;
D O I
10.2174/1872210517666230120142439
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
One of the drug delivery technologies is nanostructured lipid carriers (NLCs), which improve drug permeability and thus bioavailability. NLCs are nanoparticles made from a lipid matrix made up of a mixture of solid and liquid lipids. The inclusion of liquid lipids is useful in lowering the ordered structure of solid lipids, increasing nanoparticle loading capacity, and drug entrapment efficiency within NLCs. Hot homogenization, cold homogenization, micro-emulsion, emulsification-solvent diffusion, high shear homogenization, and/or ultrasonication techniques, double emulsion technique, melting dispersion method, membrane contractor technique, and evaporation solvent injection are some of the methods that can be used to make NLCs. Both hydrophilic and lipophilic medicines can be carried out by NLCs. They can deliver medications in a variety of ways, including oral, topical, transdermal, parenteral, and ophthalmic. During the process of preparing this review article, several distinct studies and patent reports about various methods of NLCs formulations, their various therapeutic applications, and various routes of administration were investigated and discussed. The study conducts an in-depth evaluation of the most recent research publications and patents. NLCs have been utilized to treat a variety of disorders, including cancer, fungal infections, bacterial infections, inflammation, liver diseases, and ocular infections, due to their benefits. They can deliver medications to specific locations throughout the body, allowing for drug targeting and a reduction in unwanted side effects. They can also be used to improve bioavailability, reduce the medication's supplied dose, and improve the drug's pharmacological activity.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 114 条
  • [1] In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate
    Abdelbary, Ghada
    Haider, Mohamed
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (05) : 1159 - 1168
  • [2] Quetiapine Fumarate Loaded Nanostructured Lipid Carrier for Enhancing Oral Bioavailability: Design, Development and Pharmacokinetic Assessment
    Agarwal, Shweta
    HariKumar, S. L.
    Negi, Poonam
    Upadhyay, Navneet
    Garg, Rajeev
    [J]. CURRENT DRUG DELIVERY, 2021, 18 (02) : 184 - 198
  • [3] Nanostructured Lipid Carriers (NLCs): Nose-to-brain Delivery and Theranostic Application
    Ahmad, Javed
    Rizwanullah, Md
    Amin, Saima
    Warsi, Musarrat Husain
    Ahmad, Mohammad Zaki
    Abul Barkat, Md
    [J]. CURRENT DRUG METABOLISM, 2020, 21 (14) : 1136 - 1143
  • [4] Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail
    Alam, Sohrab
    Aslam, Mohammed
    Khan, Anam
    Imam, Syed Sarim
    Aqil, Mohammed
    Sultana, Yasmin
    Ali, Asgar
    [J]. DRUG DELIVERY, 2016, 23 (02) : 601 - 609
  • [5] Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications
    Alenzi, Asma M.
    Albalawi, Sana A.
    Alghamdi, Shatha G.
    Albalawi, Rawan F.
    Albalawi, Hadeel S.
    Qushawy, Mona
    [J]. RECENT PATENTS ON NANOTECHNOLOGY, 2023, 17 (01) : 18 - 32
  • [6] Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen
    Almeida, Hugo
    Lobao, Paulo
    Frigerio, Christian
    Fonseca, Joel
    Silva, Renata
    Sousa Lobo, Jose Manuel
    Amaral, Maria Helena
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (03) : 336 - 349
  • [7] Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery
    Alshweiat, Areen
    Ambrus, Rita
    Csoka, IIdiko
    [J]. CURRENT MEDICINAL CHEMISTRY, 2019, 26 (35) : 6459 - 6492
  • [8] Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
    Andonova, Velichka
    Peneva, Petya
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) : 6630 - 6642
  • [9] Preparation and Safety Evaluation of Topical Simvastatin Loaded NLCs for Vitiligo
    Ashtiani, Sahar Yazdani
    Nasrollahi, Saman Ahmad
    Naeimifar, Atefeh
    Kashani, Aubid Nassiri
    Samadi, Aniseh
    Yadangi, Somayeh
    Aboutaleb, Ehsan
    Abdolmaleki, Poorya
    Dinarvand, Rassoul
    Firooz, Alireza
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2021, 11 (01) : 104 - 110
  • [10] Attama Anthony A, 2011, Recent Pat Drug Deliv Formul, V5, P178